An interventional study of G-tech WPS in Gastrointestinal Diseases, Ileus Paralytic and Ileus, sponsored by Yale University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-08-03.
Sponsored by Yale University · Not applicable, Interventional, and Diagnostic
The purpose of the study is to determine if the myoelectrical measurements made by the G-Tech Wireless Patch System correlate with clinical markers of postoperative recovery such as passage of flatus/bowel movement, oral tolerance of diet and discharge readiness. Subsequently the data will be studied to establish which information in the signals is important in determining when to feed patients and possibly discharge them.
These pilot prospective, open clinical studies suggests that myoelectrical activity, measured on the abdominal surface with a noninvasive wireless patch system, carries predictive value in determining time to feeding and time to flatus following open abdominal surgery. Having such information in advance of clinical measures could facilitate timely interventions, be it early feeding or delaying feeding as dictated by the patient's unique recovery profile. The G-Tech Wireless Patch System would provide a unique insight into the process allowing for a tailored protocol that could improve patient satisfaction and optimize recovery. The system could also enable feedback on the impact to the overall gastrointestinal myoelectrical activity of medications, particularly opioids, used for pain management that are known to inhibit gastrointestinal function by disrupting the normal recovery patterns of colonic motility.23-25 While it remains to be seen, in addition to predicting time to flatus/bowel movement early on, the ability to continue monitoring the patient may allow one to predict onset of secondary complications, such as wound infections or anastomotic leaks, that are associated with ileus. Similarly, given the wireless noninvasive nature of the system the patients could be discharged home with the patches, whereby they would serve as a remote monitoring tool. This could be particularly useful in cases where the patients may have been discharged early and may be at a high risk for readmission. The system would then send updates/alerts to the care team for management and potentially avoid preventable readmissions.
Gastrointestinal recovery after any visceral surgery is a complex dynamic process with multiple factors ranging from complexity of the surgery, degree of bowel handling and preoperative comorbidities affecting whether the recovery happens over few days, or is a slow prolonged affair lasting weeks. Delays in the gastrointestinal recovery process or ileus is accompanied by distention of the abdomen, pain, nausea, vomiting and the inability to tolerate oral feeding. Interventions to alleviate the ileus/distention include insertion or reinsertion of a nasogastric tube, instating nil per os and, if necessitated, parenteral nutrition. All of these factors contribute not only to patient discomfort, but extend length of stay (LOS), increase hospital resource utilization and thereby add to overall costs.
Clinically, the markers of gastrointestinal recovery are noted by passage of flatus, defecation and the ability to tolerate solid food without significant nausea and vomiting. Passage of stool or flatus - considered a surrogate for intestinal and anastomotic continuity - is often used as the trigger to start stepwise dietary orders with the patient's ability to tolerate each step marking their readiness for the subsequent meal. Fast-track and Enhanced Recovery After Surgery (ERAS) programs that promote early feeding in advance of these clinical markers, along with opioid sparing techniques and use of minimally invasive procedures have been shown to be safe and beneficial for many patients by demonstrating earlier recovery and shorter length of stay. However, it has also been shown that, for as many as 25% of cases, the strategy does not work as noted earlier, with the need for reinsertion of the nasogastric tube and reinstating nil per os status. In a recent study of 513 consecutive colorectal patients who were on an ERAS protocol, 128 patients (24.7%) needed postoperative reinsertion of nasogastric tube at the 3.9±2.9 postoperative day. This suggests that, while early postoperative feeding is beneficial to patients in whom recovery is on track, it does not work in cases where patients are not ready for it.
At present, there is no reliable measurement that can predict gastrointestinal recovery/diet readiness for patients in advance of these clinical markers that may allow for interventions or fast-track programs to facilitate timely recovery. Auscultation for return of bowel sounds, long part of the standard of care, is controversial in its usefulness to indicate recovery. Bowel sounds have shown to have poor correlation with flatus/defecation and have proved unsuccessful in guiding diet interventions.
Smooth muscle electrical activity on the other hand is directly related to gastrointestinal function and motility. Researchers have previously shown a 1:1 correlation between electrical and mechanical (contractile) events in the colon with internally placed electrode-strain gauge force transducers. Electrical activity in the colon has been reported across a wide range of frequencies ranging from 0 to 40 cycles per min (cpm)). Condon et. al have documented the progressive return of colonic electrical related to resolution of postoperative ileus and clinical recovery following surgery. These measurements have been performed using electrodes placed internally during surgery, a major impediment towards broader use of such technology.
G-Tech Medical has developed a noninvasive wireless patch system that measures electrical activity from the gastrointestinal smooth muscles on the abdominal surface. This technology has been studied as part of several non-significant risk IRB approved studies in both adults and pediatric populations to evaluate the patterns of gastrointestinal myoelectrical signals following surgery. The studies demonstrate that signals measured by the G-Tech Wireless patches correlate with clinical markers of postoperative recovery such as time to feeding and time to flatus following pancreaticoduodenectomy and general abdominal surgeries respectively. The study in patients undergoing pancreaticoduodenectomy procedures was conducted in collaboration with researchers at Stanford University. The study demonstrated that measurement of gastric activity beginning immediately after pancreaticoduodenectomy with the G-Tech Wireless Patch System, based on the measured spectral peak near 3 cpm, could distinguish patients with shorter or longer times to diet readiness. The study demonstrated the potential utility of the G-Tech Patch System in providing objective data to identify patients who are progressing as well as, or better than expected, and those who are at risk for delayed gastric emptying. In another open, prospective study, researchers examined the use of the G-Tech Wireless Patch System in predicting time to first flatus by looking at colonic myoelectrical activity following general abdominal surgeries.21 Patients with early flatus had stronger early colonic activity than patients with late flatus. At 36 h post-surgery, a linear fit of time to flatus vs cumulative colonic myoelectrical activity predicted first flatus as much as 5 days (± 22 h) before occurrence.
These pilot prospective, open clinical studies suggests that myoelectrical activity, measured on the abdominal surface with a noninvasive wireless patch system, carries predictive value in determining time to feeding and time to flatus following open abdominal surgery. Having such information in advance of clinical measures could facilitate timely interventions, be it early feeding or delaying feeding as dictated by the patient's unique recovery profile. The G-Tech Wireless Patch System would provide a unique insight into the process allowing for a tailored protocol that could improve patient satisfaction and optimize recovery. The system could also enable feedback on the impact to the overall gastrointestinal myoelectrical activity of medications, particularly opioids, used for pain management that are known to inhibit gastrointestinal function by disrupting the normal recovery patterns of colonic motility. While it remains to be seen, in addition to predicting time to flatus/bowel movement early on, the ability to continue monitoring the patient may allow one to predict onset of secondary complications, such as wound infections or anastomotic leaks, that are associated with ileus. Similarly, given the wireless noninvasive nature of the system the patients could be discharged home with the patches, whereby they would serve as a remote monitoring tool. This could be particularly useful in cases where the patients may have been discharged early and may be at a high risk for readmission. The system would then send updates/alerts to the care team for management and potentially avoid preventable readmissions.
The purpose of the Phase 1 study is to determine if the myoelectrical measurements made by the G-Tech Wireless Patch System correlate with clinical markers of postoperative recovery such as passage of flatus/bowel movement, oral tolerance of diet and discharge readiness. Subsequently the data will be studied to establish which information in the signals is important in determining when to feed patients and possibly discharge them.
167 studies on the registry are indexed under Ileus; 23 are open to participants now.
This study's enrollment of 77 is below the median of 90 across 138 interventional studies indexed under Ileus.
Browse Ileus studies →Yale University is the lead sponsor of 1,770 studies on the registry; 294 are open to participants now.
Of its 221 completed or terminated interventional studies of FDA-regulated products, 129 (58%) have results posted.
Compared within Ileus, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Gastrointestinal Diseases. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Device: G-tech WPS
G-tech WPS patches applied and activated within 4 hours of surgery
GI Functional Recovery
Time to return of flatus or bowel movement after colorectal surgery
Time frame: 30 days after index surgery
Postoperative Ileus
Occurrence of postoperative ileus after colorectal surgery
Time frame: 30 days after index surgery
Readmission With Ileus
Occurrence of readmission with postoperative ileus after colorectal surgery
Time frame: 30 days after index surgery
| Milestone | Postoperative Recovery With G-tech WPS |
|---|---|
| Started | 77 |
| Completed | 68 |
| Not completed | 9 |
| Withdrew: Physician decision | 3 |
| Withdrew: Withdrawal by subject | 2 |
| Withdrew: Lost to follow-up | 3 |
| Withdrew: Screen failure | 1 |
Time to return of flatus or bowel movement after colorectal surgery
| hours | Postoperative Recovery With G-tech WPS |
|---|---|
| GI Functional Recovery | 47.94 ± 30.78 |
Occurrence of postoperative ileus after colorectal surgery
| Participants | Postoperative Recovery With G-tech WPS |
|---|---|
| Postoperative Ileus | 6 |
Occurrence of readmission with postoperative ileus after colorectal surgery
| Participants | Postoperative Recovery With G-tech WPS |
|---|---|
| Readmission With Ileus | 0 |
Collected over 14 days of follow-up after index surgery. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Postoperative Recovery With G-tech WPS | 0/77 (0%) | 0/77 (0%) | 0/77 (0%) |
| Age, Continuous(years) | Postoperative Recovery With G-tech WPS |
|---|---|
| Mean | 62.42 ± 12.72 |
| Sex: Female, Male(Participants) | Postoperative Recovery With G-tech WPS |
|---|---|
| Female | 40 |
| Male | 37 |
| Ethnicity (NIH/OMB)(Participants) | Postoperative Recovery With G-tech WPS |
|---|---|
| Hispanic or Latino | 6 |
| Not Hispanic or Latino | 70 |
| Unknown or Not Reported | 1 |
| Race (NIH/OMB)(Participants) | Postoperative Recovery With G-tech WPS |
|---|---|
| American Indian or Alaska Native | 1 |
| Asian | 3 |
| Native Hawaiian or Other Pacific Islander | 0 |
| Black or African American | 4 |
| White | 67 |
| More than one race | 1 |
| Unknown or Not Reported | 1 |
| Height(cm) | Postoperative Recovery With G-tech WPS |
|---|---|
| Mean | 170.27 ± 10.60 |
| Weight(kg) | Postoperative Recovery With G-tech WPS |
|---|---|
| Mean | 79.88 ± 19.43 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Jun 2022 to primary completion in Sep 2024, 27 months.
Results were first posted in Aug 2025, 11 months after primary completion.
Of 40 non-industry interventional studies with no phase under Ileus, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 53. This study's 27 months is above that.
Counting every sponsor, half of 40 studies reached it within 19 months; a quarter within 7 and three quarters within 53.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.